首页> 外文OA文献 >A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: study protocol for the randomized controlled trial Treating Trauma in Psychosis
【2h】

A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: study protocol for the randomized controlled trial Treating Trauma in Psychosis

机译:多地点单盲临床研究,比较长期暴露,眼球运动减敏,再加工和等待名单对当前诊断为精神病和合并精神创伤后应激障碍的患者的影响:随机对照试验《治疗创伤》的研究方案精神病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Trauma contributes to psychosis and in psychotic disorders post-traumatic stress disorder (PTSD) is often a comorbid disorder. A problem is that PTSD is underdiagnosed and undertreated in people with psychotic disorders. This study's primary goal is to examine the efficacy and safety of prolonged exposure and eye movement desensitization and reprocessing (EMDR) for PTSD in patients with both psychotic disorders and PTSD, as compared to a waiting list. Secondly, the effects of both treatments are determined on (a) symptoms of psychosis, in particular verbal hallucinations, (b) depression and social performance, and (c) economic costs. Thirdly, goals concern links between trauma exposure and psychotic symptomatology and the prevalence of exposure to traumatic events, and of PTSD. Fourthly predictors, moderators, and mediators for treatment success will be explored. These include cognitions and experiences concerning treatment harm, credibility and burden in both participants and therapists.Methods/Design: A short PTSD-screener assesses the possible presence of PTSD in adult patients (21- to 65-years old) with psychotic disorders, while the Clinician Administered PTSD Scale interview will be used for the diagnosis of current PTSD. The M.I.N.I. Plus interview will be used for diagnosing lifetime psychotic disorders and mood disorders with psychotic features. The purpose is to include consenting participants (N = 240) in a multi-site single blind randomized clinical trial. Patients will be allocated to one of three treatment conditions (N = 80 each): prolonged exposure or EMDR (both consisting of eight weekly sessions of 90 minutes each) or a six-month waiting list. All participants are subjected to blind assessments at pre-treatment, twomonths post treatment, and six monthspost treatment. In addition, participants in the experimental conditions will have assessments at mid treatment and at 12 months follow-up.Discussion: The results from the post treatment measurement can be considered strong empirical indicators of the safety and effectiveness of prolonged exposure and EMDR. The six-month and twelve-month follow-up data have the potential of reliably providing documentation of the long-term effects of both treatments on the various outcome variables. Data from pre-treatment and midtreatment can be used to reveal possible pathways of change.
机译:背景:创伤会导致精神病,并且在精神病中,创伤后应激障碍(PTSD)通常是合并症。问题在于精神病患者的PTSD诊断不足和治疗不足。这项研究的主要目的是,与精神病患者和候补患者相比,检查长期暴露以及对PTSD的精神病性障碍和PTSD患者的眼睛运动脱敏和再加工(EMDR)的有效性和安全性。其次,两种治疗的效果取决于(a)精神病症状,尤其是口头幻觉,(b)抑郁和社会表现,以及(c)经济成本。第三,目标关注创伤暴露与精神病症状学,创伤事件和PTSD患病率之间的联系。第四,将探讨治疗成功的预测因素,调节者和中介者。方法/设计:简短的PTSD筛选器评估了患有精神病的成年患者(21岁至65岁)中PTSD的可能存在,同时对参与者和治疗师的认知和经验也有涉及。临床医生管理的PTSD量表访谈将用于诊断当前的PTSD。 M.I.N.I. Plus访谈将用于诊断终生精神病和具有精神病特征的情绪障碍。目的是在多站点单盲随机临床试验中纳入同意的参与者(N = 240)。患者将被分配到以下三种治疗条件之一(每组N = 80):长时间暴露或EMDR(均由每8分钟一次的每周八次疗程,每次90分钟组成)或六个月的等待名单。在治疗前,治疗后两个月和治疗后六个月对所有参与者进行盲目评估。此外,实验条件的参与者将在治疗中期和随访12个月进行评估。讨论:治疗后测量的结果可被视为长期暴露和EMDR的安全性和有效性的有力经验指标。六个月和十二个月的随访数据有可能可靠地提供两种治疗对各种结果变量的长期影响的文献记录。预处理和中间处理的数据可用于揭示变化的可能途径。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号